Ameritas Investment Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Buy |
4,439
+284
| +7% | +$14.5K | 0.01% | 1226 |
|
|
2025
Q1 | $187K | Hold |
4,155
| – | – | 0.01% | 1300 |
|
|
2024
Q4 | $172K | Buy |
4,155
+312
| +8% | +$12.9K | 0.01% | 1417 |
|
|
2024
Q3 | $150K | Hold |
3,843
| – | – | ﹤0.01% | 1526 |
|
|
2024
Q2 | $131K | Buy |
3,843
+1,206
| +46% | +$41.2K | ﹤0.01% | 1555 |
|
|
2024
Q1 | $66.2K | Hold |
2,637
| – | – | ﹤0.01% | 1990 |
|
|
2023
Q4 | $77.8K | Hold |
2,637
| – | – | ﹤0.01% | 1902 |
|
|
2023
Q3 | $83.3K | Buy |
2,637
+429
| +19% | +$13.6K | ﹤0.01% | 1779 |
|
|
2023
Q2 | $57.1K | Buy |
2,208
+1,016
| +85% | +$26.3K | ﹤0.01% | 1967 |
|
|
2023
Q1 | $28.6K | Hold |
1,192
| – | – | ﹤0.01% | 2305 |
|
|
2022
Q4 | $25.6K | Hold |
1,192
| – | – | ﹤0.01% | 2453 |
|
|
2022
Q3 | $25K | Hold |
1,192
| – | – | ﹤0.01% | 2410 |
|
|
2022
Q2 | $23K | Buy |
1,192
+967
| +430% | +$18.7K | ﹤0.01% | 2486 |
|
|
2022
Q1 | $5K | Hold |
225
| – | – | ﹤0.01% | 2971 |
|
|
2021
Q4 | $4K | Hold |
225
| – | – | ﹤0.01% | 3061 |
|
|
2021
Q3 | $4K | Hold |
225
| – | – | ﹤0.01% | 3048 |
|
|
2021
Q2 | $4K | Hold |
225
| – | – | ﹤0.01% | 3009 |
|
|
2021
Q1 | $4K | Hold |
225
| – | – | ﹤0.01% | 3030 |
|
|
2020
Q4 | $4K | Hold |
225
| – | – | ﹤0.01% | 3002 |
|
|
2020
Q3 | $4K | Hold |
225
| – | – | ﹤0.01% | 3011 |
|
|
2020
Q2 | $4K | Hold |
225
| – | – | ﹤0.01% | 2996 |
|
|
2020
Q1 | $3K | Hold |
225
| – | – | ﹤0.01% | 2919 |
|
|
2019
Q4 | $6K | Hold |
225
| – | – | ﹤0.01% | 2880 |
|
|
2019
Q3 | $2K | Buy |
+225
| New | +$2K | ﹤0.01% | 3024 |
|